Oxler Private Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Oxler Private Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$823K	Hold	1,575	–	–	0.22%	49
2026 Q2	$782K	Sell	1,575 -57	-3%	-$25.3K	0.22%	49
2026 Q1	$729K	Hold	1,632	–	–	0.23%	49
2025 Q4	$740K	Hold	1,632	–	–	0.21%	51
2025 Q3	$639K	Sell	1,632 -42	-3%	-$17.6K	0.19%	57
2025 Q2	$745K	Hold	1,674	–	–	0.23%	51
2025 Q1	$812K	Sell	1,674 -110	-6%	-$51.3K	0.29%	47
2024 Q4	$718K	Hold	1,784	–	–	0.24%	52
2024 Q3	$830K	Hold	1,784	–	–	0.29%	47
2024 Q2	$836K	Hold	1,784	–	–	0.31%	46
2024 Q1	$746K	Buy	+1,784	New	+$754K	0.29%	52
2023 Q4	–	Sell	-1,796	Closed	-$625K	–	93
2023 Q3	$625K	Hold	1,796	–	–	0.31%	61
2023 Q2	$632K	Sell	1,796 -101	-5%	-$34K	0.3%	65
2023 Q1	$598K	Hold	1,897	–	–	0.3%	66
2022 Q4	$548K	Hold	1,897	–	–	0.29%	66
2022 Q3	$549K	Hold	1,897	–	–	0.31%	69
2022 Q2	$535K	Buy	+1,897	New	+$508K	0.26%	76

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Oxler Private Wealth's VRTX Position: Q3 2026 in Review

Oxler Private Wealth held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 1,575 shares worth $823K. The position accounts for 0.22% of the portfolio, ranked #49.

Oxler Private Wealth first reported a position in VRTX in Q2 2022 and has held it in 17 quarters since. The position peaked at $836K in Q2 2024. 870 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

Oxler Private Wealth held 1,575 shares of Vertex Pharmaceuticals worth $823K as of Q3 2026.
Oxler Private Wealth left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
Vertex Pharmaceuticals made up 0.22% of Oxler Private Wealth's portfolio in Q3 2026, its #49 holding.
Oxler Private Wealth first reported a position in Vertex Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
Oxler Private Wealth's Vertex Pharmaceuticals position peaked at $836K in Q2 2024.
870 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Oxler Private Wealth's 13F filing for Q3 2026, filed 21 Oct 2026.